Cwbio (SHG: 688426)

Cwbio is a corporation based in Taizhou, China. Established in 2007, the firm is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials, enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents, and others. The assets are managed by the executive team.